Matched mutations and long term letrozole for breast cancer
Matched mutations and long term letrozole for breast cancer
neoMONARCH: CDK inhibition for HR positive, HER negative breast cancer
Oestrogen deprivation inffective with chemo for HR/HER positive breast cancer
No benefit for adjuvant ibandronate at 3 years in early breast cancer
PARP inhibitory velaparib trialled in BRCA1/2 breast cancer
Matched mutations in the progression of metastatic breast cancer
Comparison between standard and reduced volume radiotherapy in bladder preservation trimodality protocol for muscle-invasive bladder cancer patients
Positive impact of specialised surgery in the fight against cancer
Infographic: Addressing unmet needs in metastatic breast cancer
The need to better understand pathways that drive ER+ metastatic breast cancer
A focus on gynecologic oncology in publishing
The México Salud-Hable coalition